EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Can 177 Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data

Azadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, Johan Blakkisrud, Sara Kurkowska, Surekha Yadav, Chang Wang, Carlos Uribe, Caroline Stokke, Arman Rahmim, Ka Kit Wong, Jean-Mathieu Beauregard und 3 weitere

Journal of Nuclear Medicine · 22.05.2025 · jnumed.124.269098

DOI: 10.2967/jnumed.124.269098 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 22.05.2025. Verfasst von Azadeh Akhavanallaf und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Octreotide, Receptors, Somatostatin, Organometallic Compounds, Kidney. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Before performing 177Lu-DOTATATE therapy for neuroendocrine tumors, somatostatin receptor (SSTR) PET imaging is currently used to confirm sufficient tumor SSTR expression, but it also has potential to be used to personalize treatment by predicting absorbed doses to critical organs. This study aims to validate the predictive capability of SSTR PET in anticipating renal absorbed dose in the first cycle of 177Lu-DOTATATE using a multicenter dataset to analyze and derive insights from a broader patient population.

Methods

Retrospective data from 5 centers were included in this study: 1 in Canada (n = 25), 1 in Norway (n = 75), 1 in Sweden (n = 18), and 2 in the United States (n = 36 and n = 26). At each center, pretherapy SSTR PET/CT imaging and postcycle 1 177Lu imaging-based dosimetry were performed according to site-specific protocols. The mixed-effects model treating centers as random effects was developed using baseline SSTR PET renal uptake values to predict renal absorbed dose from 177Lu-DOTATATE. Additionally, leave-one-center-out cross-validation and leave-one-sample-out cross-validation were implemented for external and internal validation, respectively, measuring mean absolute error and mean relative absolute error.

Results

Across all participating centers, the median cycle 1 renal absorbed dose was 0.56 Gy/GBq (range, 0.14-1.27 Gy/GBq), whereas the median pretherapy SSTR PET renal uptake was 110.7 Bq/mL/MBq (range, 28.6-287.7 Bq/mL/MBq). The differences among center means were statistically significant for both absorbed dose and PET uptake (P < 0.0001 from 1-way ANOVA). A significant (P < 0.05) correlation was observed between kidney SSTR PET uptake and 177Lu-DOTATATE absorbed dose for each center (center-specific coefficient of determination ranged from 0.14 to 0.53). When data across all centers were aggregated, the mixed-effects model achieved a coefficient of determination of 0.25 (P < 0.01), resulting in an mean absolute error of 0.15 Gy/GBq (SD, 0.11 Gy/GBq) and an mean relative absolute error of 28% (SD, 24%) for external validation and 0.12 Gy/GBq (SD, 0.10 Gy/GBq) and 22% (SD, 20%) for internal validation.

Conclusion

The correlations observed between SSTR PET renal uptake and 177Lu-DOTATATE absorbed dose to kidneys across a multicenter population are statistically significant yet modest. The prediction model achieved a mean relative absolute error 28% or less for both external and internal validation of PET-predicted absorbed doses. The intercenter differences suggest the need for standardized imaging protocols and dosimetry workflows.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OctreotideReceptors, SomatostatinOrganometallic CompoundsKidneyPositron Emission Tomography Computed TomographyRadiation DosageHumansMaleFemaleRetrospective StudiesMiddle AgedNeuroendocrine TumorsAgedAdultRadiometry

Stichwörter der Autor:innen

177Lu-DOTATATE PRRTSSTR PET/CTabsorbed dose predictiondosimetry

Substanzen

Octreotidelutetium Lu 177 dotatateReceptors, SomatostatinOrganometallic Compounds

Autor:innen und Institutionen

  • Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
  • Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan; zhonglil@umich.edu.
  • Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.
  • Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
  • Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
  • Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.

Förderung

  • NCI NIH HHS

Zitieren

APA

Akhavanallaf, A., Lu, Z., Peterson, A. B., Blakkisrud, J., Kurkowska, S., Yadav, S., Wang, C., Uribe, C., Stokke, C., Rahmim, A., Wong, K. K., Beauregard, J. M., Hope, T. A., Sjögreen Gleisner, K., & Dewaraja, Y. K. (2025). Can 177 Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data. Journal of Nuclear Medicine, jnumed.124.269098. https://doi.org/10.2967/jnumed.124.269098

Vancouver

Akhavanallaf A, Lu Z, Peterson AB, Blakkisrud J, Kurkowska S, Yadav S, et al. Can 177 Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data. Journal of Nuclear Medicine. 2025:jnumed.124.269098. doi:10.2967/jnumed.124.269098

BibTeX
@article{Akhavanallaf2025,
  author = {Akhavanallaf, Azadeh and Lu, Zhonglin and Peterson, Avery B and Blakkisrud, Johan and Kurkowska, Sara and Yadav, Surekha and Wang, Chang and Uribe, Carlos and Stokke, Caroline and Rahmim, Arman and Wong, Ka Kit and Beauregard, Jean-Mathieu and Hope, Thomas A and Sjögreen Gleisner, Katarina and Dewaraja, Yuni K},
  title = {Can 177 Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  pages = {jnumed.124.269098},
  doi = {10.2967/jnumed.124.269098}
}
Kostenlos starten →